Isoprenaline Hydrochloride

Drugs with no patents and no competition – here’s our list of new ‘price-gouging’ targets

Drug price increases have emerged as a core strategy for generic pharmaceutical companies in the rec

Making a fortune out of decades-old prescription drugs

The importance of taking the right decision in product selection, by the senior management at pharma